Marilyne Labrie

Sherbrooke, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

CCR2- T peripheral helper cells as potential coordinators of local immune architecture in human cancer.

CCR2- T peripheral helper cells as potential coordinators of local immune architecture in human cancer.

Journal: Discovery immunology

Published: October 21, 2025

ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer.

ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: October 20, 2025

Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancer.

Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancer.

Journal: Oncogene

Published: November 15, 2024

CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer.

CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer.

Journal: The Journal of clinical investigation

Published: October 24, 2024

A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies.

A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2024

Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with PARP and ATR inhibitors combination.

Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with PARP and ATR inhibitors combination.

Journal: Nature communications

Published: August 22, 2024

Current preclinical models of brain metastasis.

Current preclinical models of brain metastasis.

Journal: Clinical & experimental metastasis

Published: July 26, 2024

T peripheral helper (Tph) cells, a marker of immune activation in cancer and autoimmune disorders.

T peripheral helper (Tph) cells, a marker of immune activation in cancer and autoimmune disorders.

Journal: Clinical immunology (Orlando, Fla.)

Published: July 03, 2024

Enhancing anticancer activity of macrophages through rational drug combinations.

Enhancing anticancer activity of macrophages through rational drug combinations.

Journal: The Journal of clinical investigation

Published: May 01, 2024

The Breast Cancer Proteome and Precision Oncology.

The Breast Cancer Proteome and Precision Oncology.

Journal: Cold Spring Harbor perspectives in medicine

Published: May 03, 2023

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Journal: American journal of human genetics

Published: July 13, 2022

Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies.

Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies.

Journal: Expert review of proteomics

Published: April 25, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026